$ELDN
Eledon Pharmaceuticals, Inc.

2019 Q3 Form 10-Q Financial Statement

#000156459019031785 Filed on August 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.410M $1.790M $1.860M
YoY Change -23.78% -3.76% -69.66%
% of Gross Profit
Research & Development $1.509M $2.297M $1.329M
YoY Change -8.6% 72.84% 149.34%
% of Gross Profit
Depreciation & Amortization $10.00K $0.00 $10.00K
YoY Change -100.0%
% of Gross Profit
Operating Expenses $2.920M $4.089M $3.189M
YoY Change -16.55% 28.22% -52.16%
Operating Profit -$2.920M -$4.089M -$3.189M
YoY Change -16.55% 28.22% -52.16%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $27.00K -$4.000K $0.00
YoY Change 800.0% -100.0%
Pretax Income -$2.890M -$4.090M -$3.190M
YoY Change -17.43% 28.21% -52.1%
Income Tax
% Of Pretax Income
Net Earnings -$2.893M -$4.093M -$3.189M
YoY Change -17.25% 28.35% -52.13%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$4.014M -$6.292M -$6.135M
COMMON SHARES
Basic Shares Outstanding 12.97M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.80M $13.70M $19.20M
YoY Change -33.74% -28.65% -14.67%
Cash & Equivalents $10.81M $13.70M $19.19M
Short-Term Investments
Other Short-Term Assets $15.00K $78.00K $15.00K
YoY Change 0.0% 420.0% -99.35%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.30M $15.18M $21.08M
YoY Change -28.14% -27.98% -15.16%
LONG-TERM ASSETS
Property, Plant & Equipment $7.000K $10.00K $20.00K
YoY Change -58.82% -50.0% -59.18%
Goodwill $1.867M $1.867M $1.867M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $688.0K $755.0K
YoY Change -26.34%
Total Long-Term Assets $2.922M $3.035M $1.887M
YoY Change 3.69% 60.84% -5.7%
TOTAL ASSETS
Total Short-Term Assets $12.30M $15.18M $21.08M
Total Long-Term Assets $2.922M $3.035M $1.887M
Total Assets $15.22M $18.22M $22.97M
YoY Change -23.64% -20.68% -14.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $256.0K $753.0K $706.0K
YoY Change -65.91% 6.66% 88.77%
Accrued Expenses $1.400M $1.200M $700.0K
YoY Change 55.56% 71.43% -52.89%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.661M $1.948M $1.500M
YoY Change 3.81% 29.87% -52.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $200.0K $200.0K
YoY Change
Total Long-Term Liabilities $200.0K $200.0K $0.00
YoY Change -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.661M $1.948M $1.500M
Total Long-Term Liabilities $200.0K $200.0K $0.00
Total Liabilities $1.852M $2.184M $1.452M
YoY Change 15.53% 50.41% -57.36%
SHAREHOLDERS EQUITY
Retained Earnings -$53.44M -$50.55M -$33.50M
YoY Change 44.44% 50.88% 49.38%
Common Stock $66.80M $66.58M $55.01M
YoY Change 20.75% 21.02% 19.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.37M $16.03M $21.51M
YoY Change
Total Liabilities & Shareholders Equity $15.22M $18.22M $22.97M
YoY Change -23.64% -20.68% -14.45%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income -$2.893M -$4.093M -$3.189M
YoY Change -17.25% 28.35% -52.13%
Depreciation, Depletion And Amortization $10.00K $0.00 $10.00K
YoY Change -100.0%
Cash From Operating Activities -$2.880M -$4.930M -$3.340M
YoY Change -1.71% 47.6% -42.01%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 9.570M 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -2.880M -4.930M -3.340M
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000 9.570M 0.000
Net Change In Cash -2.880M 4.640M -3.340M
YoY Change 0.7% -238.92% -116.46%
FREE CASH FLOW
Cash From Operating Activities -$2.880M -$4.930M -$3.340M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-4093000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-3189000
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Shell Company
EntityShellCompany
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12974923
dei Entity File Number
EntityFileNumber
001-36620
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
201000967
dei Entity Address Address Line1
EntityAddressAddressLine1
19900 MacArthur Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 550
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
California
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
dei City Area Code
CityAreaCode
(949)
dei Local Phone Number
LocalPhoneNumber
238-8090
CY2019Q2 us-gaap Assets Current
AssetsCurrent
15181000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
14276000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
403000
CY2019Q2 us-gaap Goodwill
Goodwill
1867000
CY2019Q2 us-gaap Cash
Cash
13703000
CY2018Q4 us-gaap Cash
Cash
12972000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1478000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1304000
CY2018Q4 us-gaap Goodwill
Goodwill
1867000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
755000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
869000
CY2019Q2 us-gaap Assets
Assets
18216000
CY2018Q4 us-gaap Assets
Assets
17026000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
753000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
689000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
173000
CY2019Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1022000
CY2018Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1845000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1948000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2534000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
236000
CY2019Q2 us-gaap Liabilities
Liabilities
2184000
CY2018Q4 us-gaap Liabilities
Liabilities
2534000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
565000
us-gaap Operating Lease Payments
OperatingLeasePayments
89000
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0325
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3189000
us-gaap Operating Expenses
OperatingExpenses
8964000
us-gaap Operating Expenses
OperatingExpenses
5984000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4089000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
13000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
9000
CY2019Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
66564000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
56054000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-50545000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-41571000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
16032000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
14492000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18216000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17026000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8582723
nvus Share Issuance At Market Value
ShareIssuanceAtMarketValue
107000
nvus Stock Issued During Period Value Common Stock And Warrants
StockIssuedDuringPeriodValueCommonStockAndWarrants
9569000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
838000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
9929000
CY2019Q2 nvus Stock Issued During Period Value Common Stock And Warrants
StockIssuedDuringPeriodValueCommonStockAndWarrants
9569000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
627000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
19452000
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12974923
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9422143
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12974923
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9422143
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2297000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1329000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5286000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2426000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1792000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1860000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3678000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3558000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
4089000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
3189000
us-gaap Operating Income Loss
OperatingIncomeLoss
-8964000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5984000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11000
us-gaap Net Income Loss
NetIncomeLoss
-8974000
us-gaap Net Income Loss
NetIncomeLoss
-5995000
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.35
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.85
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.70
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11751110
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9407024
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10595511
nvus Share Issuance At Market Value
ShareIssuanceAtMarketValue
7491000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
404000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
4000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
5000
nvus Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
86000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
838000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
565000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
60000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
192000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-759000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
12000
nvus Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-80000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8945000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5605000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9676000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7491000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9676000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7491000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
731000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1886000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12972000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17303000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13703000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
19189000
CY2018Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2019Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
489000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
91000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
188000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
146000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
425000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.86%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company&#8217;s financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s unaudited condensed consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s financial statements relate to stock-based compensation, accruals for liabilities, operating lease liability, carrying value of goodwill, and other matters that affect the condensed consolidated financial statements and related disclosures. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the <font style="color:#000000;">condensed </font>consolidated financial statements. </p>
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
409000
CY2019Q1 nvus Milestone Payment Made
MilestonePaymentMade
300000
CY2018 nvus Effective Federal And State Income Tax Rate
EffectiveFederalAndStateIncomeTaxRate
0.21
nvus Effective Federal And State Income Tax Rate
EffectiveFederalAndStateIncomeTaxRate
0.21
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
626000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
404000
us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2019Q2 nvus Net Loss Used In The Calculation Of Basic And Diluted Loss Per Share
NetLossUsedInTheCalculationOfBasicAndDilutedLossPerShare
-4093000
CY2018Q2 nvus Net Loss Used In The Calculation Of Basic And Diluted Loss Per Share
NetLossUsedInTheCalculationOfBasicAndDilutedLossPerShare
-3189000
CY2019Q2 nvus Working Capital
WorkingCapital
13200000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0
CY2018Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q2 us-gaap Prepaid Insurance
PrepaidInsurance
396000
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
413000
CY2019Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
265000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
84000
nvus Lessee Operating Lease Remaining Term Of Contract
LesseeOperatingLeaseRemainingTermOfContract
P2Y3M
CY2019Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
0
us-gaap Operating Lease Cost
OperatingLeaseCost
97000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
261000
CY2019Q2 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
739000
CY2018Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
583000
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
78000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
47000
CY2019Q2 nvus Accrued Clinical Current
AccruedClinicalCurrent
419000
CY2018Q4 nvus Accrued Clinical Current
AccruedClinicalCurrent
735000
CY2019Q2 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
238000
CY2018Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
194000
CY2019Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
200000
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
160000
CY2019Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
149000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
742000
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14000
CY2018Q2 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
42000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
95000

Files In Submission

Name View Source Status
0001564590-19-031785-index-headers.html Edgar Link pending
0001564590-19-031785-index.html Edgar Link pending
0001564590-19-031785.txt Edgar Link pending
0001564590-19-031785-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nvus-10q_20190630.htm Edgar Link pending
nvus-20190630.xml Edgar Link completed
nvus-20190630.xsd Edgar Link pending
nvus-20190630_cal.xml Edgar Link unprocessable
nvus-20190630_def.xml Edgar Link unprocessable
nvus-20190630_lab.xml Edgar Link unprocessable
nvus-20190630_pre.xml Edgar Link unprocessable
nvus-ex311_10.htm Edgar Link pending
nvus-ex312_7.htm Edgar Link pending
nvus-ex321_8.htm Edgar Link pending
nvus-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending